Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glofinn is a regenerative medicine and medical device company focused on platelet-rich plasma and related autologous blood-processing systems. The company appears to operate through entities including Glofinn Oy in Finland, Glofinn America LLC in the United States, and a South Korean manufacturing or affiliated entity, and markets the GLO PRP system for preparation of platelet-rich plasma and related blood-derived products for human and animal use. Its products are positioned for tissue regeneration, rejuvenation, healing, wound care, dermatology, hair restoration, and orthopedic or sports-medicine style applications rather than traditional drug development. Available evidence suggests Glofinn is a commercial-stage healthcare company centered on PRP kits, consumables, and blood-processing devices rather than a therapeutic biotech with a conventional clinical drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glofinn.